Beijing Advaccine Biotechnology has raised 200 million yuan ($29 million) in a Series B round funding from MatrixPartners, Star Capital, and others, while Baidu’s Smart Living Group (SLG) has secured an undisclosed Series A from Baidu, CPE, and IDG.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
